Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Kubzansky, Ichiro Kawachi, A. Spiro, S. Weiss, P. Vokonas, D. Sparrow (1997)
Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study.Circulation, 95 4
A. Biegon, N. Essar, M. Israeli, A. Elizur, Shlomo Bruch, Aliezer Bar-Nathan (2005)
Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorderPsychopharmacology, 102
S. Kasper, J. Fuger, H.J. Moller (1992)
Comparative efficacy of antidepressantsDrugs, 43
MaryBeth Lake, B. Birmaher, Susan Wassick, Kimberly Mathos, Ann Yelovich (2000)
Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence.Journal of child and adolescent psychopharmacology, 10 1
A.A. Ariyo, M. Haan, C.M. Tangen (2000)
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans: Cardiovascular Health Study Collaborative Research GroupCirculation, 102
D. Layton, D.W. Clark, G.L. Pearce (2001)
Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding?.: results from a cohort study based on prescription event monitoring in EnglandEur J Clin Pharmacol, 57
A. Nelva, C. Guy, B. Tardy-Poncet (2000)
Syndrômes hémorragiques sous antidépresseurs inhibiteurs sélectifs de la recapture de la sérotonine (ISRS): a propos de sept cas et revue de la littératureRev Med Interne, 21
P. Celada, M. Dolera, E. Álvarez, F. Artigas (1992)
Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement.Journal of affective disorders, 25 4
A. Appels, P. Mulder (1988)
Excess fatigue as a precursor of myocardial infarction.European heart journal, 9 7
L. Pratt, D. Ford, R. Crum, H. Armenian, Joseph Gallo, W. Eaton (1996)
Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up.Circulation, 94 12
P. Vanhoutte (1991)
Platelet‐Derived Serotonin, the Endothelium, and Cardiovascular DiseaseJournal of Cardiovascular Pharmacology, 17
D. Musselman, U. Marzec, A. Manatunga, S. Penna, A. Reemsnyder, B. Knight, Aimee Baron, S. Hanson, C. Nemeroff (2000)
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.Archives of general psychiatry, 57 9
D.W. Gunzberger, D. Martinez (1992)
Adverse vascular effects associated with fluoxetine [letter]Am J Psychiatry, 149
A. Nelva, C. Guy, B. Tardy-Poncet, M. Beyens, M. Ratrema, C. Benedetti, M. Ollagnier (2000)
Syndromes hémorragiques sous antidépresseurs inhibiteurs sélectifs de la recapture de la sérotonine (ISRS). A propos de sept cas et revue de la littératureRevue de Médecine Interne, 21
Ottervanger Jp, Stricker Bh, J. Huls, Weeda Jn (1994)
Bleeding attributed to the intake of paroxetine.The American journal of psychiatry, 151 5
Wei Jiang, R. Krishnan, C. O'connor (2002)
Depression and Heart DiseaseCNS Drugs, 16
D. Lane, Douglas Carroll, Christopher Ring, D. Beevers, Lip Gy (2001)
Mortality and Quality of Life 12 Months After Myocardial Infarction: Effects of Depression and AnxietyPsychosomatic Medicine, 63
D. Ford, L. Mead, P. Chang, L. Cooper-Patrick, Nae-Yuh Wang, M. Klag (1998)
Depression is a risk factor for coronary artery disease in men: the precursors study.Archives of internal medicine, 158 13
Luis Rodríguez, S. Gutthann (1998)
Use of the UK General Practice Research Database for pharmacoepidemiology.British journal of clinical pharmacology, 45 5
Carlos Leon, H. Krumholz, Teresa Seeman, V. Vaccarino, Christianna Williams, S. Kasl, L. Berkman (1998)
Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982-1991. Established Populations for the Epidemiologic Studies of the Elderly.Archives of internal medicine, 158 21
B. Weber-Hamann, F. Hentschel, A. Kniest, M. Deuschle, M. Colla, F. Lederbogen, I. Heuser (2002)
Hypercortisolemic Depression Is Associated With Increased Intra-Abdominal FatPsychosomatic Medicine, 64
S. Kimmel, S. Kimmel, J. Berlin, C. Miles, Jane Jaskowiak, J. Carson, B. Strom (2001)
Risk of acute first myocardial infarction and use of nicotine patches in a general population.Journal of the American College of Cardiology, 37 5
J. Yaryura-Tobias, H. Kirschen, P. Ninan, H. Mosberg (1991)
Fluoxetine and bleeding in obsessive-compulsive disorder.The American journal of psychiatry, 148 7
A. Biegon, Abraham Weizman, L. Karp, A. Ram, S. Tiano, M. Wolff (1987)
Serotonin 5-HT2 receptor binding on blood platelets--a peripheral marker for depression?Life sciences, 41 22
J. Barefoot, M. Schroll (1996)
Symptoms of depression, acute myocardial infarction, and total mortality in a community sample.Circulation, 93 11
J. Lefkovits, E. Plow, E. Topol (1995)
Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine.The New England journal of medicine, 332 23
D. Layton, D. Clark, G. Pearce, S. Shakir (2001)
Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding?European Journal of Clinical Pharmacology, 57
D. Musselman, A. Tomer, A. Manatunga, B. Knight, M. Porter, Suha Kasey, U. Marzec, L. Harker, C. Nemeroff (1996)
Exaggerated platelet reactivity in major depression.The American journal of psychiatry, 153 10
N. Frasure-smith, F. Lespérance, M. Juneau, M. Talajic, M. Bourassa (1999)
Gender, depression, and one-year prognosis after myocardial infarction.Psychosomatic medicine, 61 1
P. Shapiro, F. Lespérance, N. Frasure-smith, C. O’Connor, B. Baker, Jan Jiang, P. Dorian, W. Harrison, A. Glassman (1999)
An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial.American heart journal, 137 6
G. Nair, P. Gurbel, C. O'connor, W. Gattis, S. Murugesan, V. Serebruany (1999)
Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.The American journal of cardiology, 84 3
C. Nemeroff, E. Widerlöv, G. Bissette, H. Walleus, I. Karlsson, K. Eklund, C. Kilts, P. Loosen, W. Vale (1984)
Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.Science, 226 4680
J. Schlechte, T. Coffman (1985)
Plasma free cortisol in depressive illness--a review of findings and clinical implications.Psychiatric medicine, 3 1
V. Menys, C. Smith, P. Lewins, R. Farmer, M. Noble (1996)
Platelet 5-hydroxytryptamine is decreased in a preliminary group of depressed patients receiving the 5-hydroxytryptamine re-uptake inhibiting drug fluoxetine.Clinical science, 91 1
Calhoun Jw, Calhoun Dd (1996)
Prolonged bleeding time in a patient treated with sertraline.The American journal of psychiatry, 153 3
C. Walraven, M. Mamdani, P. Wells, J. Williams (2001)
Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort studyBMJ : British Medical Journal, 323
L. Costa, J. Silva, J. Silva (2001)
Superovulatory response, embryo quality and fertility after treatment with different gonadotrophins in native cattle.Theriogenology, 56
A. Rozanski, J. Blumenthal, Jay Kaplan (1999)
Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.Circulation, 99 16
H. Jick, S. Jick, L. Derby (1991)
Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.British Medical Journal, 302
Ramesh Arora, H. Meltzer (1989)
Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.Life sciences, 44 11
V. Serebruany, V. Serebruany, P. Gurbel, P. Gurbel, Christopher O'Connor, Christopher O'Connor (2001)
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.Pharmacological research, 43 5
B. Skop, Thomas Brown (1996)
Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.Psychosomatics, 37 1
R. Veith, N. Lewis, O. Linares, R. Barnes, M. Raskind, E. Villacres, M. Murburg, E. Ashleigh, S. Castillo, E. Peskind, M. Pascualy, J. Halter (1994)
Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics.Archives of general psychiatry, 51 5
D. Buff, R. Brenner, S. Kirtane, R. Gilboa (1991)
Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease.The Journal of clinical psychiatry, 52 4
B.W.J.H. Penninx, A. Beekman, A. Honig, Dorly Deeg, R. Schoevers, J. Eijk, W. Tilburg (2001)
Depression and cardiac mortality: results from a community-based longitudinal study.Archives of general psychiatry, 58 3
M. Mhanna, J. Bennet, S. Izatt (1997)
Potential fluoxetine chloride (Prozac) toxicity in a newborn.Pediatrics, 100 1
J. Markovitz, K. Matthews (1991)
Platelets and coronary heart disease: potential psychophysiologic mechanisms.Psychosomatic Medicine, 53
J. Murphy, R. Monson, D. Olivier, A. Sobol, A. Leighton (1987)
Affective disorders and mortality. A general population study.Archives of general psychiatry, 44 5
K. Rickels, E. Schweizer (1990)
Clinical overview of serotonin reuptake inhibitors.The Journal of clinical psychiatry, 51 Suppl B
Tracy Cooper, Victor Valcour, R. Gibbons, Kelly O’Brien-Falls (1998)
Spontaneous ecchymoses due to paroxetine administration.The American journal of medicine, 104 2
F. Clerck (1991)
Effects of serotonin on platelets and blood vesselsJ Cardiovasc Pharmacol, 17
J.W. Calhoun, D.D. Calhoun (1996)
Prolonged bleeding time in a patient treated with sertraline [letter]Am J Psychiatry, 153
F. Clerck (1990)
The role of serotonin in thrombogenesis.Clinical physiology and biochemistry, 8
M. Shores, M. Pascualy, N. Lewis, D. Flatness, R. Veith (2001)
Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjectsPsychoneuroendocrinology, 26
F. Abajo, Hershel Jick, L. Derby, S. Jick, Stephen Schmitz (2000)
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.British journal of clinical pharmacology, 50 1
S. Roose, A. Glassman, Evelyn Attia, Sally Woodring, E. Giardina, J. Bigger (1998)
Cardiovascular effects of fluoxetine in depressed patients with heart disease.The American journal of psychiatry, 155 5
F. Laghrissi-Thode, W. Wagner, B. Pollock, Peter Johnson, M. Finkel (1997)
Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart diseaseBiological Psychiatry, 42
S. Everson, D. Goldberg, G. Kaplan, R. Cohen, E. Pukkala, J. Tuomilehto, J. Salonen (1996)
Hopelessness and Risk of Mortality and Incidence of Myocardial Infarction and CancerPsychosomatic Medicine, 58
T. Vogt, C. Pope, J. Mullooly, J. Hollis (1994)
Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization.American journal of public health, 84 2
Gunzberger Dw, D. Martinez (1992)
Adverse vascular effects associated with fluoxetine.The American journal of psychiatry, 149 12
J. Strik, A. Honig, M. Maes (2001)
Depression and myocardial infarction: relationship between heart and mindProgress in Neuro-Psychopharmacology and Biological Psychiatry, 25
R. Shader, D. Greenblatt (2001)
Selective serotonin reuptake inhibitor antidepressants: cardiovascular complications--sorting through findings.Journal of clinical psychopharmacology, 21 5
F. Abajo, L. Rodríguez, D. Montero (1999)
Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control studyBMJ, 319
P. Vandel, S. Vandel, J.P. Kantelip (2001)
Saignements et inhibiteurs de la recapture de la sérotonine: à propos de deux casTherapie, 56
F. Lederbogen, M. Gilles, A. Maras, B. Hamann, M. Colla, I. Heuser, M. Deuschle (2001)
Increased platelet aggregability in major depression?Psychiatry Research, 102
R. France, B. Urban, K. Krishnan, G. Bissett, C. Bánki, C. Nemeroff, Frederick Speilman (1988)
CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depressionBiological Psychiatry, 23
A. Ferketich, J. Schwartzbaum, D. Frid, M. Moeschberger (2000)
Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey.Archives of internal medicine, 160 9
C. Berg, F. Couturier, F. Grass, O. Aujoulat, D. Guillard, C. Stoeckel (2001)
[Bleeding from selective serotonin reuptake inhibitors: a case report].Therapie, 56 1
A. Forrester, J. Lipsey, Mark Teitelbaum, J. Depaulo, P. Andrzejewski, Robert Robinson (1992)
Depression following Myocardial InfarctionThe International Journal of Psychiatry in Medicine, 22
C. Hayward (1995)
Psychiatric illness and cardiovascular disease risk.Epidemiologic reviews, 17 1
G. Anfossi, M. Trovati (1996)
Role of catecholamines in platelet function: pathophysiological and clinical significanceEuropean Journal of Clinical Investigation, 26
J. Humphries, M. Wheby, S. Vandenberg (1990)
Fluoxetine and the bleeding time.Archives of pathology & laboratory medicine, 114 7
S. Wassertheil-Smoller, W. Applegate, K. Berge, C. Chang, B. Davis, R. Grimm, J. Kostis, S. Pressel, E. Schron (1996)
Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly).Archives of internal medicine, 156 5
A. Glassman, Ana Rodriguez, Peter Shapiro (1998)
The use of antidepressant drugs in patients with heart disease.The Journal of clinical psychiatry, 59 Suppl 10
J. Strik, A. Honig, R. Lousberg, A. Lousberg, E. Cheriex, H. Tuynman-Qua, Petra Kuijpers, H. Wellens, H. Praag (2000)
Efficacy and Safety of Fluoxetine in the Treatment of Patients With Major Depression After First Myocardial Infarction: Findings From a Double-Blind, Placebo-Controlled TrialPsychosomatic Medicine, 62
Tielens Ja (1997)
Vitamin C for paroxetine- and fluvoxamine-associated bleeding.American Journal of Psychiatry, 154
M. Javors, J. Houston, J. Tekell, S. Brannan, A. Frazer (2000)
Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine.The international journal of neuropsychopharmacology, 3 3
C. Berg, F. Couturier, F. Grass (2001)
Saignements sous inhibiteurs de la recapture de la sérotonine: à propos d’un cas cliniqueTherapie, 56
M. Leung, Resa Shore (1996)
Fluvoxamine-Associated BleedingThe Canadian Journal of Psychiatry, 41
B. Malzberg (1937)
MORTALITY AMONG PATIENTS WITH INVOLUTION MELANCHOLIAAmerican Journal of Psychiatry, 93
P.T. Wilmshurst, A.V. Kumar (1996)
Subhyaloid haemorrhage with fluoxetine [letter]Eye, 10
P. Wilmshurst, A. Kumar (1996)
Subhyaloid haemorrhage with fluoxetineEye, 10
T. Hällström, L. Lapidus, C. Bengtsson, Kristina Edström (1986)
Psychosocial factors and risk of ischaemic heart disease and death in women: a twelve-year follow-up of participants in the population study of women in Gothenburg, Sweden.Journal of psychosomatic research, 30 4
B. Torre, J. Dreher, Iaroslav Malevany, M. Bagli, M. Kolbinger, H. Omran, B. Lüderitz, M. Rao (2001)
Serum Levels and Cardiovascular Effects of Tricyclic Antidepressants and Selective Serotonin Reuptake Inhibitors in Depressed PatientsTherapeutic Drug Monitoring, 23
S. Bak, I. Tsiropoulos, J. Kjærsgaard, M. Andersen, E. Mellerup, J. Hallas, L. Rodríguez, K. Christensen, D. Gaist (2002)
Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: A Population-Based Case-Control StudyStroke: Journal of the American Heart Association, 33
A. Glassman, P. Shapiro (1998)
Depression and the course of coronary artery disease.The American journal of psychiatry, 155 1
A. Ariyo, M. Haan, C. Tangen, J. Rutledge, M. Cushman, A. Dobs, C. Furberg (2000)
Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly AmericansCirculation: Journal of the American Heart Association, 102
N. Hergovich, M. Aigner, H. Eichler, J. Entlicher, C. Drucker, B. Jilma (2000)
Paroxetine decreases platelet serotonin storage and platelet function in human beingsClinical Pharmacology & Therapeutics, 68
J. Ellison, J. Milofsky, E. Ely (1990)
Fluoxetine-induced bradycardia and syncope in two patients.The Journal of clinical psychiatry, 51 9
Anita Weeke, Knud Juel, Michael Vaeth (1987)
Cardiovascular death and manic-depressive psychosis.Journal of affective disorders, 13 3
W. Jiang, R.R. Krishnan, C.M. O’Connor (2002)
Depression and heart disease: evidence of a link, and its therapeutic implicationsCNS Drugs, 16
D.E. Ford, L.A. Mead, P.P. Chang (1998)
Depression is a risk factor for coronary artery disease in menArch Intern Med, 158
J. Irvine, A. Basiński, B. Baker, Stacey Jandciu, M. Paquette, J. Cairns, S. Connolly, R. Roberts, M. Gent, P. Dorian (1999)
Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue.Psychosomatic medicine, 61 6
T. Walley, A. Mantgani (1997)
The UK General Practice Research DatabaseThe Lancet, 350
C. Meier, R. Schlienger, H. Jick (2001)
Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.British journal of clinical pharmacology, 52 2
S. Roose, F. Laghrissi-Thode, J. Kennedy, J. Nelson, J. Bigger, B. Pollock, A. Gaffney, M. Narayan, M. Finkel, J. Mccafferty, I. Gergel (1998)
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.JAMA, 279 4
M. Walsh, T. Dinan, R. Condren, M. Ryan, D. Kenny (2002)
Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib.Life sciences, 70 26
J. Barefoot, R. Williams (2000)
Antidepressant use and the risk of myocardial infarction.The American journal of medicine, 108 1
T.G. Evans, S.S. Buys, G.M. Rodgers (1991)
Acquired abnormalities in platelet function [letter]N Engl J Med, 324
D. Musselman, Dwight Evans, C. Nemeroff (1998)
The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment.Archives of general psychiatry, 55 7
C. Bánki, G. Bissette, M. Arato, L. O'Connor, C. Nemeroff (1987)
CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.The American journal of psychiatry, 144 7
J. Strik, A. Honig, R. Lousberg, E. Cheriex, H. Praag (1998)
Cardiac side‐effects of two selective serotonin reuptake inhibitors in middle- aged and elderly depressed patientsInternational Clinical Psychopharmacology, 13
I. Anderson (2000)
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.Journal of affective disorders, 58 1
B. Carroll, G. Curtis, B. Davies, J. Mendels, A. Sugerman (1976)
Urinary free Cortisol excretion in depressionPsychological Medicine, 6
J. Aranth, C. Lindberg (1992)
Bleeding, a side effect of fluoxetine [letter]Am J Psychiatry, 149
R. Wyatt, B. Portnoy, D. Kupfer, F. Snyder, K. Engelman (1971)
Resting plasma catecholamine concentrations in patients with depression and anxiety.Archives of general psychiatry, 24 1
P. Blardi, A. Lalla, A. Leo, A. Auteri, S. Iapichino, A. Muro, A. Dell'erba, P. Castrogiovanni (2002)
Serotonin and Fluoxetine Levels in Plasma and Platelets After Fluoxetine Treatment in Depressive PatientsJournal of Clinical Psychopharmacology, 22
P. Vandel, S. Vandel, J. Kantelip (2001)
SSRI-induced bleeding: two case reports.Therapie, 56 4
M. Zarzar, R. Kingsley (1990)
Use of fluoxetine in a person with cardiac arrhythmias.Psychosomatics, 31 2
Charles Nemeroff, D. Musselman (2000)
Are platelets the link between depression and ischemic heart disease?American heart journal, 140 4 Suppl
H. Jick, B. Terris, L. Derby, S. Jick (1992)
Further validation of information recorded on a general practitioner based computerized data resource in the united kingdomPharmacoepidemiology and Drug Safety, 1
J.A. Yaryura-Tobias, H. Kirschen, P. Ninan (1991)
Am J Psychiatry
N. Frasure-smith, F. Lespérance, M. Talajic (1993)
Depression following myocardial infarction. Impact on 6-month survival.JAMA, 270 15
R. Anda, D. Williamson, Diane Jones, C. Macera, E. Eaker, A. Glassman, J. Marks (1993)
Depressed Affect, Hopelessness, and the Risk of Ischemic Heart Disease in a Cohort of U.S. AdultsEpidemiology, 4
S. Schleifer, M. Macari-Hinson, D. Coyle, WILLIAM Slater, M. Kahn, R. Gorlin, H. Zucker (1989)
The nature and course of depression following myocardial infarction.Archives of internal medicine, 149 8
K. Ladwig, G. Roll, G. Breithard, T. Budde, M. Borggrefe (1994)
Post-infarction depression and incomplete recovery 6 months after acute myocardial infarctionThe Lancet, 343
A. Aromaa, R. Raitasalo, A. Reunanen, O. Impivaara, M. Heliövaara, P. Knekt, V. Lehtinet, M. Joukamaa, J. Maatela (1994)
Depression and cardiovascular diseasesActa Psychiatrica Scandinavica, 89
H. Cohen, Geoffrey Gibson, M. Alderman (2000)
Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents.The American journal of medicine, 108 1
A. Glassman, C. O’Connor, R. Califf, K. Swedberg, P. Schwartz, J. Bigger, K. Krishnan, Louis Zyl, J. Swenson, M. Finkel, Charles Landau, P. Shapiro, C. Pepine, J. Mardekian, W. Harrison, D. Barton, Michael Mclvor (2002)
Sertraline treatment of major depression in patients with acute MI or unstable anginaEuropean Neuropsychopharmacology, 12
P. Gold, D. Loriaux, Alec Roy, M. Kling, Joseph Calabrese, Charles Kellner, Lynnette Nieman, Robert Post, David Pickar, W. Gallucci, P. Avgerinos, Steven Paul, E. Oldfield, G. Cutler, G. Chrousos (1986)
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.The New England journal of medicine, 314 21
W. Sauer, J. Berlin, S. Kimmel (2001)
Selective Serotonin Reuptake Inhibitors and Myocardial InfarctionCirculation: Journal of the American Heart Association, 104
C. Alderman, Claire Moritz, D. Ben‐Tovim (1992)
Abnormal Platelet Aggregation Associated with Fluoxetine TherapyAnnals of Pharmacotherapy, 26
E. Simonsick, R. Wallace, D. Blazer, L. Berkman (1995)
Depressive Symptomatology and Hypertension-Associated Morbidity and Mortality in Older AdultsPsychosomatic Medicine, 57
B. Pollock, F. Laghrissi-Thode, W. Wagner (2000)
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.Journal of clinical psychopharmacology, 20 2
D. Muck-Šeler, M. Jakovljevič, Živan Deanović (1991)
Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.Journal of affective disorders, 23 3
N. Frasure-smith, F. Lespérance, M. Talajic (1995)
Depression and 18-month prognosis after myocardial infarction.Circulation, 91 4
J. Barbey, S. Roose (1998)
SSRI safety in overdose.The Journal of clinical psychiatry, 59 Suppl 15
J. Aranth, C. Lindberg (1992)
Bleeding, a side effect of fluoxetine.The American journal of psychiatry, 149 3
J. Markovitz, J. Shuster, William Chitwood, R. May, L. Tolbert (2000)
Platelet activation in depression and effects of sertraline treatment: An open-label study.The American journal of psychiatry, 157 6
In recent years a large body of evidence from several longitudinal studies has emerged suggesting that depression is an independent risk factor for cardiovascular disease (CVD) and that the association between depression and increased CVD risk is not merely due to negative mood-driven behavior related with depression. Even though the underlying mechanisms are not well understood, several hypotheses and explanations have been proposed such as increased activation of the hypothalamic-pituitary-adrenal axis, abnormalities in the sympathoadrenal system, or abnormalities in platelet function. Platelet function abnormalities, including increased platelet reactivity, may predispose patients with depressive disorders to clotting diatheses and may explain their vulnerability to CVD.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Sep 20, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.